EP3206711

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    13.10.2015
  • EP published:
    31.5.2023
  • EP application number:
    15784907.6
  • Max expiry date:
    12.10.2035
  • Title in English:
    ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF
  • Language of the patent:
    English

Timeline

Today
13.10.2015EP application
31.5.2023EP Publication

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056 Basel, CH
  • Name:
    Dana-Farber Cancer Institute, Inc.
  • Address:
    450 Brookline Avenue, Boston, MA 02215-5450, US
  • Name:
    President and Fellows of Harvard College
  • Address:
    17 Quincy Street, Cambridge, MA 02138, US

Inventor

  • Name:
    FREEMAN, Gordon, James
  • Address:
    Brookline, MA 02445, US
  • Name:
    SHARPE, Arlene, Helen
  • Address:
    Brookline, MA 02445, US
  • Name:
    FREY, Gerhard, Johann
  • Address:
    San Diego, CA 92129, US
  • Name:
    CHANG, Hwai, Wen
  • Address:
    San Marcos, CA 92069, US
  • Name:
    MATARAZA, Jennifer, Marie
  • Address:
    Cambridgem, MA 02139, US
  • Name:
    DRANOFF, Glenn
  • Address:
    Cambridge, MA 02139, US

Priority

  • Number:
    201462063852 P
  • Date:
    14.10.2014
  • Country:
    US
  • Number:
    201462094847 P
  • Date:
    19.12.2014
  • Country:
    US
  • Number:
    201562198545 P
  • Date:
    29.7.2015
  • Country:
    US
  • Number:
    201562213076 P
  • Date:
    1.9.2015
  • Country:
    US

Classification

  • Categories:
    A61K 39/395, C07K 16/28, C07K 16/46, C07K 16/30, A61P 31/00, A61P 35/00, A61P 35/02, A61P 37/02

Upload documents